Dr. Dmitry Karayev, MD

Dr. Karayev practices at Cedars-Sinai Medical Center in Los Angeles, California, part of Cedars-Sinai Health System.

Dr. Karayev's NPI, 1174783260, was assigned on June 11, 2008. Dr. Karayev graduated from Tufts University School Of Medicine in 2006. Dr. Karayev's California license number on file is A103031.

Dr. Karayev's primary practice is Cedars-Sinai Medical Center, at 8700 Beverly Blvd, Los Angeles, CA 90048 in Los Angeles County. The practice phone is (310) 423-5000.

Dr. Karayev's primary practice is Cedars-Sinai Medical Center in Los Angeles, California, part of Cedars-Sinai Health System. The medical group on file is Center For Rheumatology. Dmand AI also links Dr. Karayev to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Karayev practices, 2 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Karayev's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Karayev is board certified in rheumatology by the American Board of Internal Medicine. Dr. Karayev has a license on file in California.

Dmand AI lists arteritis, arthritis, gout, lupus, muscle disease, muscle pain, fibromyalgia, and limb pain, osteoporosis and rheumatoid arthritis among the conditions Dr. Karayev treats.

CMS data shows 57,220 Medicare services from Dr. Karayev across 66 procedure codes in 2024, for 357 Medicare patients. Medicare paid $776,140 for them. Every service was in an office.

CMS counts 357 Medicare patients who saw Dr. Karayev in 2024. The largest group is 75 to 84, with 155 patients. 75% of them have arthritis, and 75% have high cholesterol. 8% are also on Medicaid. Their average risk score is 1.46, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Karayev's median patient age at 55, with 67% women.

In 2024, Dr. Karayev wrote 1,881 Medicare Part D claims for 192 patients. 77% of them were for generic drugs. CMS names the drug for 1,444 of them, across 51 drugs with 11 or more claims each, at $1,305,647 in total drug cost. In 2023, CMS named 1,247 claims across 46 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 99 out of 100 for Dr. Karayev for performance year 2024, reported as part of a group. Dr. Karayev accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Karayev as offering telehealth.

CMS Open Payments shows 232 general payments to Dr. Karayev from 22 drug and device companies from 2016 to 2025. Honoraria make up the largest share, 66% of the total. Inova Diagnostics, Inc. paid the most, $11,919.

Dmand AI lists 1 award for Dr. Karayev.

Dr. Karayev graduated from Tufts University School Of Medicine in 2006.

Dr. Karayev is in network with 7 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Blue Cross Blue Shield of Massachusetts. Medicare plans come from the most carriers, 7. Check the plan with the practice before a visit.